New Research: Eliminating Drugmaker Rebates Leads to Significantly Higher Medicare Part D Premiums for Seniors
Manufacturers have chosen to negotiate price concessions with PBMs using rebates, which are paid months after a drug has been dispensed and are used by payers to reduce premiums and out-of-pocket costs for patients. At this time, rebates are the only usable price concession available.
Key findings from the analysis ā "Premium Impact of Removing Manufacturer Rebates from the Medicare Part D Program," include:
- Part D plan-negotiated manufacturer rebates have resulted in
$34.9 billion in beneficiary premium savings for enrollees from 2014 to 2018. - In 2017, the average Part D monthly premium of
$35.63 would have been 45 percent, or$16.07 , higher without rebates. - In 2018, the average Part D monthly premium of
$35.03 would have been 52 percent, or$18.36 , higher without rebates. - On an annual basis, the 2018 Part D premium would have increased from
$420.24 to$640.56 without rebates.
"Public programs like Medicaid and MedicareĀ useĀ rebates on brand drugs to offset highĀ prices.Ā Simply eliminating plans' ability toĀ negotiate such price concessions would enrich drugmakersĀ at the expense of patients, who'd faceĀ higher premiums and out-of-pocket costs," said PCMA President and CEO
PCMA commissioned
PCMA is the national association representing America's pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, Medicaid plans, and others.
View original content with multimedia:http://www.prnewswire.com/news-releases/new-research-eliminating-drugmaker-rebates-leads-to-significantly-higher-medicare-part-d-premiums-for-seniors-300681329.html
SOURCE
The global blockchain in insurance market size is expected to grow from USD 64.5 million in 2018 to USD 1,393.8 million by 2023, at a Compound Annual Growth Rate (CAGR) of 84.9%
Finland protests: Human rights for all _ and save the planet
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News